VC-backed SteadyMed sets IPO pricing terms
SteadyMed Ltd, a specialty pharmaceutical company based in San Ramon, California and Israel, has priced its IPO of 4.25 million shares at between $12 and $14 per share. SteadyMed plans on listing the stock on the NASDAQ under the ticker symbol "STDY." Wells Fargo Securities LLC and RBC Capital Markets LLC are the lead underwriters. SteadyMed's backers include Samson Venture Partners, Deerfield Management and Federated Investors.
10 March 2015•2 mins read
